Healios KK (HLOSF)
1.50
0.00 (0.00%)
USD |
OTCM |
Nov 14, 16:00
Healios EPS Diluted (Quarterly): -0.038 for June 30, 2024
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -0.038 |
| March 31, 2024 | -0.1957 |
| December 31, 2023 | -0.1655 |
| September 30, 2023 | -0.0692 |
| June 30, 2023 | -0.0756 |
| March 31, 2023 | -0.0871 |
| December 31, 2022 | -0.1386 |
| September 30, 2022 | -0.0891 |
| June 30, 2022 | -0.2518 |
| March 31, 2022 | -0.2279 |
| December 31, 2021 | -0.2472 |
| September 30, 2021 | -0.3166 |
| June 30, 2021 | -0.1524 |
| March 31, 2021 | -0.2369 |
| December 31, 2020 | -0.2781 |
| September 30, 2020 | -0.2575 |
| June 30, 2020 | -0.2434 |
| March 31, 2020 | -0.2261 |
| December 31, 2019 | -0.3298 |
| Date | Value |
|---|---|
| September 30, 2019 | -0.1865 |
| June 30, 2019 | -0.191 |
| March 31, 2019 | -0.1727 |
| December 31, 2018 | -0.1871 |
| September 30, 2018 | -0.1339 |
| June 30, 2018 | -0.516 |
| March 31, 2018 | -0.1037 |
| December 31, 2017 | -0.1062 |
| September 30, 2017 | -0.1769 |
| June 30, 2017 | 0.0361 |
| March 31, 2017 | -0.1126 |
| December 31, 2016 | -0.0739 |
| September 30, 2016 | -0.1086 |
| June 30, 2016 | -0.1181 |
| March 31, 2016 | -0.4551 |
| December 31, 2015 | -0.0789 |
| September 30, 2015 | -0.0331 |
| June 30, 2015 | -0.0415 |
| March 31, 2015 | -0.0603 |
Earnings per Share Definition
Earnings per share measures the total net income / average shares outstanding during income period. There are a few variations to earnings per share that are listed including "EPS Basic", "EPS Diluted", "Normalized Basic EPS", and "Normalized Diluted EPS". Each of these metrics are dependent on which earnings and shares outstanding metrics are used. Basic and Diluted EPS differ in that diluted shares are the amount of shares outstanding after all convertible securities, options, and warrants are exercised. Normalized EPS allows does not include one-time expenses.
EPS Diluted (Quarterly) Range, Past 5 Years
-0.3298
Minimum
Dec 2019
-0.038
Maximum
Jun 2024
-0.1909
Average
-0.2261
Median
Mar 2020
EPS Diluted (Quarterly) Benchmarks
| Takeda Pharmaceutical Co Ltd | 0.1924 |
| Nxera Pharma Co Ltd | 0.0906 |
| PeptiDream Inc | 0.9276 |
| AnGes Inc | -0.1057 |
| SanBio Co Ltd | -0.108 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -3.426M |
| Revenue (Quarterly) | 3.195M |
| Total Expenses (Quarterly) | 5.004M |
| Enterprise Value | 117.61M |
| Gross Profit Margin (Quarterly) | 86.35% |
| Profit Margin (Quarterly) | -107.2% |
| Earnings Yield | -31.22% |
| Normalized Earnings Yield | -31.22 |